# UNIVEST FINANCIAL Corp: overview

UVSP · Nasdaq · CIK 102212 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uvsp.md) · [Financials](/companies/uvsp/financials.md) · [Filings](/companies/uvsp/filings.md) · [Insiders](/companies/uvsp/insiders.md)

Latest reported revenue: [$84.4m](/filings/0000102212-26-000037.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 28, 2026 (XBRL us-gaap:Revenues, accession 0000102212-26-000037).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [73.4](/filings/0000102212-25-000028.md) | [76.8 d](/filings/0000102212-26-000012.md) | [79.2](/filings/0000102212-26-000028.md) | [81.0](/filings/0000102212-26-000037.md) | [83.2](/filings/0000102212-25-000028.md) | [84.6 d](/filings/0000102212-26-000012.md) | [87.5](/filings/0000102212-26-000028.md) | [84.4](/filings/0000102212-26-000037.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [25.3%](/filings/0000102212-25-000028.md) | [24.7% d](/filings/0000102212-26-000012.md) | [28.3%](/filings/0000102212-26-000028.md) | [24.7%](/filings/0000102212-26-000037.md) | [30.8%](/filings/0000102212-25-000028.md) | [26.9% d](/filings/0000102212-26-000012.md) | [31.0%](/filings/0000102212-26-000028.md) | [27.2%](/filings/0000102212-26-000037.md) |
| Diluted EPS | $ per share | [0.63](/filings/0000102212-25-000028.md) | not reported | [0.77](/filings/0000102212-26-000028.md) | [0.69](/filings/0000102212-26-000037.md) | [0.89](/filings/0000102212-25-000028.md) | not reported | [0.96](/filings/0000102212-26-000028.md) | [0.82](/filings/0000102212-26-000037.md) |
| Free cash flow | $m | [38.3 d](/filings/0000102212-25-000028.md) | [27.4 d](/filings/0000102212-26-000012.md) | [13.7](/filings/0000102212-26-000028.md) | [21.9 d](/filings/0000102212-26-000037.md) | [31.4 d](/filings/0000102212-25-000028.md) | [30.0 d](/filings/0000102212-26-000012.md) | [21.6](/filings/0000102212-26-000028.md) | [22.9 d](/filings/0000102212-26-000037.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0000102212-22-000009.md) | [296](/filings/0000102212-25-000006.md) | [297](/filings/0000102212-26-000012.md) | [299](/filings/0000102212-26-000012.md) | [328](/filings/0000102212-26-000012.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [26.4%](/filings/0000102212-25-000006.md) | [24.0%](/filings/0000102212-26-000012.md) | [25.4%](/filings/0000102212-26-000012.md) | [27.7%](/filings/0000102212-26-000012.md) |
| Diluted EPS | $ per share | [3.11](/filings/0000102212-24-000010.md) | [2.64](/filings/0000102212-25-000006.md) | [2.41](/filings/0000102212-26-000012.md) | [2.58](/filings/0000102212-26-000012.md) | [3.13](/filings/0000102212-26-000012.md) |
| Free cash flow | $m | [96.5](/filings/0000102212-24-000010.md) | [104](/filings/0000102212-25-000006.md) | [83.0](/filings/0000102212-26-000012.md) | [72.0](/filings/0000102212-26-000012.md) | [96.9](/filings/0000102212-26-000012.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/uvsp/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $149.5m | 3,417,251 |  | Added +306,159 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $83.0m | 1,896,670 |  | Added +10,435 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $68.7m | 1,570,525 |  | Reduced −331,799 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $52.0m | 1,187,660 |  | Reduced −29,683 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $43.4m | 991,985 |  | Added +58,299 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $37.0m | 846,282 |  | Added +88,280 |
| [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $36.5m | 834,628 |  | Reduced −7,797 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $36.0m | 823,655 |  | Added +32,711 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $33.4m | 764,026 |  | Reduced −331,529 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $22.6m | 515,789 |  | Reduced −67,945 |

## Recent filings

[All 1,534 filings](/companies/uvsp/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-28 | 14:15 ET | [10-Q](/filings/0000102212-26-000037.md) | Quarterly report, period 2026-06-30 | 0000102212-26-000037 |
| 2026-07-27 | 16:42 ET | [8-K](/filings/0000102212-26-000035.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000102212-26-000035 |
| 2026-07-23 | 08:30 ET | [8-K](/filings/0000102212-26-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000102212-26-000033 |
| 2026-04-28 | 14:22 ET | [10-Q](/filings/0000102212-26-000028.md) | Quarterly report, period 2026-03-31 | 0000102212-26-000028 |
| 2026-04-24 | 08:54 ET | [8-K](/filings/0000102212-26-000024.md) | 5.07 Shareholder vote results | 0000102212-26-000024 |
| 2026-04-23 | 08:46 ET | [8-K](/filings/0000102212-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000102212-26-000022 |
| 2026-04-02 | 15:32 ET | [8-K](/filings/0000102212-26-000019.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000102212-26-000019 |
| 2026-03-13 | 09:25 ET | [DEF 14A](/filings/0000102212-26-000015.md) | Proxy statement, period 2025-12-31 | 0000102212-26-000015 |
| 2026-02-23 | 15:50 ET | [10-K](/filings/0000102212-26-000012.md) | Annual report, period 2025-12-31 | 0000102212-26-000012 |
| 2026-02-10 | 13:05 ET | [8-K](/filings/0001193125-26-044136.md) | 8.01 Other events | 0001193125-26-044136 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000102212-26-000012.md), filed Feb 23, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c013034a-5b9c-4379-9c39-afccf652cfe3)

## About the filer

- CIK: 102212
- Tickers: UVSP
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: PA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 08:32 ET. No prices; not investment advice.